Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
55.9M
-
Shares change
-
+6.46M
-
Total reported value, excl. options
-
$147M
-
Value change
-
+$17.8M
-
Put/Call ratio
-
0.13
-
Number of buys
-
48
-
Number of sells
-
-38
-
Price
-
$2.62
Significant Holders of Xeris Biopharma Holdings, Inc. - COM (XERS) as of Q2 2023
116 filings reported holding XERS - Xeris Biopharma Holdings, Inc. - COM as of Q2 2023.
Xeris Biopharma Holdings, Inc. - COM (XERS) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.9M shares
.
Largest 10 shareholders include BlackRock Inc. (9.33M shares), VANGUARD GROUP INC (6.95M shares), CAXTON CORP (5.64M shares), Stonepine Capital Management, LLC (5.5M shares), BIOIMPACT CAPITAL LLC (3.97M shares), GEODE CAPITAL MANAGEMENT, LLC (2.68M shares), STATE STREET CORP (2.54M shares), Invesco Ltd. (2.1M shares), Soleus Capital Management, L.P. (2.05M shares), and MILLENNIUM MANAGEMENT LLC (1.81M shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.